{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:32:28Z","timestamp":1792092748803,"version":"4.4.0"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.18425","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T16:31:00Z","timestamp":1577464260000},"page":"e1918425","source":"Crossref","is-referenced-by-count":59,"title":["Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker\u2013Induced Lower-Extremity Edema With Loop Diuretics"],"prefix":"10.1001","volume":"2","author":[{"given":"Scott Martin","family":"Vouri","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville"},{"name":"Center for Drug Evaluation and Safety, University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Manini","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Safety, University of Florida, Gainesville"},{"name":"Department of Aging and Geriatric Research, University of Florida College of Medicine, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence M.","family":"Solberg","sequence":"additional","affiliation":[{"name":"Department of Aging and Geriatric Research, University of Florida College of Medicine, Gainesville"},{"name":"Geriatric Research, Education, and Clinical Center, Malcom Randall North Florida\/South Georgia VA Medical Center, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Pepine","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, University of Florida College of Medicine, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Malone","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut G.","family":"Winterstein","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville"},{"name":"Center for Drug Evaluation and Safety, University of Florida, Gainesville"},{"name":"Department of Epidemiology, University of Florida College of Medicine, Gainesville"},{"name":"College of Public Health and Health Professions, University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,12,27]]},"reference":[{"issue":"10","key":"zoi190694r1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics 2019 update: a report from the American Heart Association.","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"17","key":"zoi190694r2","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"issue":"9246","key":"zoi190694r3","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials: Blood Pressure Lowering Treatment Trialists\u2019 Collaboration.","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"issue":"13","key":"zoi190694r4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.CIR.102.13.1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events.","volume":"102","author":"Pitt","year":"2000","journal-title":"Circulation"},{"issue":"9080","key":"zoi190694r5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension.","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"zoi190694r6","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"8","key":"zoi190694r8","article-title":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.","author":"Li","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi190694r9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/1871525713666150310111554","article-title":"Calcium channel blockers in the management of hypertension in the elderly.","volume":"12","author":"Caballero-Gonzalez","year":"2015","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"7","key":"zoi190694r10","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/HJH.0b013e3283472643","article-title":"Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate: a meta-analysis of randomized trials.","volume":"29","author":"Makani","year":"2011","journal-title":"J Hypertens"},{"issue":"9, pt 1","key":"zoi190694r11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0895-7061(01)02178-1","article-title":"Vasodilatory edema: a common side effect of antihypertensive therapy.","volume":"14","author":"Messerli","year":"2001","journal-title":"Am J Hypertens"},{"issue":"6","key":"zoi190694r12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11886-002-0110-9","article-title":"Vasodilatory edema: a common side effect of antihypertensive therapy.","volume":"4","author":"Messerli","year":"2002","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"zoi190694r13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jch.2003.5.issue-4","article-title":"Calcium channel blocker-related peripheral edema: can it be resolved?","volume":"5","author":"Sica","year":"2003","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"20","key":"zoi190694r14","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.jacc.2019.03.467","article-title":"Deprescribing in older adults with cardiovascular disease.","volume":"73","author":"Krishnaswami","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"7115","key":"zoi190694r15","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","article-title":"Optimising drug treatment for elderly people: the prescribing cascade.","volume":"315","author":"Rochon","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"zoi190694r16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jgs.2019.67.issue-5","article-title":"Assessing the scope and appropriateness of prescribing cascades.","volume":"67","author":"McCarthy","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"zoi190694r17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance.","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"issue":"8","key":"zoi190694r18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s11255-016-1304-1","article-title":"Urinary incontinence and diuretic avoidance among adults with chronic kidney disease.","volume":"48","author":"Patel","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"zoi190694r19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0300-2977(95)90003-9","article-title":"Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward.","volume":"44","author":"van Kraaij","year":"1994","journal-title":"Neth J Med"},{"issue":"6","key":"zoi190694r20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2165\/00002512-200825060-00002","article-title":"Management of acute renal failure in the elderly patient: a clinician\u2019s guide.","volume":"25","author":"Cheung","year":"2008","journal-title":"Drugs Aging"},{"issue":"2","key":"zoi190694r21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40266-013-0145-1","article-title":"Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence.","volume":"31","author":"Tannenbaum","year":"2014","journal-title":"Drugs Aging"},{"issue":"9","key":"zoi190694r22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/jch.2004.6.issue-9","article-title":"Diuretic-related side effects: development and treatment.","volume":"6","author":"Sica","year":"2004","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"zoi190694r23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/pds.v21.5","article-title":"New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home.","volume":"21","author":"Berry","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"zoi190694r24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/ageing\/29.6.489","article-title":"Inappropriate use of loop diuretics in elderly patients.","volume":"29","author":"Kelly","year":"2000","journal-title":"Age Ageing"},{"issue":"6","key":"zoi190694r25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jamda.2013.02.002","article-title":"Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs.","volume":"14","author":"Wehling","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"11","key":"zoi190694r26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40266-015-0306-5","article-title":"Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009.","volume":"32","author":"Corrao","year":"2015","journal-title":"Drugs Aging"},{"issue":"2","key":"zoi190694r27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","article-title":"Diuretic initiation and the acute risk of hip fracture.","volume":"24","author":"Berry","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"zoi190694r28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1715163516640811","article-title":"Prescribing cascade in an elderly woman.","volume":"149","author":"Nguyen","year":"2016","journal-title":"Can Pharm J (Ott)"},{"issue":"5","key":"zoi190694r29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.japh.2018.06.014","article-title":"An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade.","volume":"58","author":"Vouri","year":"2018","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"7","key":"zoi190694r30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamainternmed.2019.1288","article-title":"The dangers of ignoring the Beers criteria: the prescribing cascade.","volume":"179","author":"DeRhodes","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"5","key":"zoi190694r31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","article-title":"Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis.","volume":"7","author":"Hallas","year":"1996","journal-title":"Epidemiology"},{"issue":"5","key":"zoi190694r32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pds.v22.5","article-title":"The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection.","volume":"22","author":"Wahab","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"zoi190694r33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","article-title":"Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies.","volume":"32","author":"Lai","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"zoi190694r34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pds.3498","article-title":"Use of antiepileptic drugs and risk of hypothyroidism.","volume":"22","author":"Lai","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"zoi190694r35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/joim.2014.275.issue-6","article-title":"Use of self-controlled designs in pharmacoepidemiology.","volume":"275","author":"Hallas","year":"2014","journal-title":"J Intern Med"},{"issue":"9596","key":"zoi190694r36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"zoi190694r37","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs.","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"8","key":"zoi190694r40","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/pds.3780","article-title":"Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.","volume":"24","author":"Pratt","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"zoi190694r41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bcp.2010.69.issue-2","article-title":"Misdiagnosis and mistreatment of a common side-effect: angiotensin-converting enzyme inhibitor-induced cough.","volume":"69","author":"Vegter","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"zoi190694r42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40264-013-0029-7","article-title":"Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis.","volume":"36","author":"van Boven","year":"2013","journal-title":"Drug Saf"},{"issue":"8","key":"zoi190694r43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/jhh.2008.157","article-title":"Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system.","volume":"23","author":"de la Sierra","year":"2009","journal-title":"J Hum Hypertens"},{"issue":"2","key":"zoi190694r44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/jhh.2016.46","article-title":"High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis.","volume":"31","author":"He","year":"2017","journal-title":"J Hum Hypertens"},{"issue":"5","key":"zoi190694r45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/MBP.0000000000000061","article-title":"Randomized trial comparing the effects of a low-dose combination of nifedipine GITS and valsartan versus high-dose monotherapy on central hemodynamics in patients with inadequately controlled hypertension: FOCUS Study.","volume":"19","author":"Park","year":"2014","journal-title":"Blood Press Monit"},{"issue":"1","key":"zoi190694r46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00126097-200102000-00008","article-title":"Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses.","volume":"6","author":"Hern\u00e1ndez","year":"2001","journal-title":"Blood Press Monit"},{"issue":"5","key":"zoi190694r47","first-page":"682","article-title":"Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.","volume":"14","author":"Lefebvre","year":"1998","journal-title":"Can J Cardiol"},{"issue":"2","key":"zoi190694r48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jch.2005.7.issue-2","article-title":"Prescribing patterns of diuretics in multi-drug antihypertensive regimens.","volume":"7","author":"Singh","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"zoi190694r49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40264-013-0024-z","article-title":"The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis.","volume":"36","author":"Vegter","year":"2013","journal-title":"Drug Saf"},{"issue":"1","key":"zoi190694r50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12874-017-0457-7","article-title":"A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.","volume":"18","author":"Takeuchi","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"zoi190694r51","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/jgs.12741","article-title":"Risk of medication-associated initiation of oxybutynin in elderly men and women.","volume":"62","author":"Kalisch Ellett","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"zoi190694r52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/archinternmed.2011.1029","article-title":"Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis.","volume":"172","author":"Garrison","year":"2012","journal-title":"Arch Intern Med"},{"issue":"2","key":"zoi190694r53","first-page":"231","article-title":"Appropriate prescribing of medications: an eight-step approach.","volume":"75","author":"Pollock","year":"2007","journal-title":"Am Fam Physician"},{"issue":"5","key":"zoi190694r54","first-page":"316","article-title":"Teaching the ESSEnCE of office-based prescribing.","volume":"38","author":"Bazaldua","year":"2006","journal-title":"Fam Med"},{"key":"zoi190694r55","doi-asserted-by":"publisher","first-page":"vii36","DOI":"10.1093\/annonc\/mdt266","article-title":"Polypharmacy and the management of the older cancer patient.","volume":"24","author":"Balducci","year":"2013","journal-title":"Ann Oncol"},{"issue":"7","key":"zoi190694r56","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40264-018-0650-6","article-title":"Using the symmetry analysis design to screen for adverse effects of non-vitamin K antagonist oral anticoagulants.","volume":"41","author":"Hellfritzsch","year":"2018","journal-title":"Drug Saf"},{"issue":"8","key":"zoi190694r57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104519","article-title":"Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis.","volume":"9","author":"McCormick","year":"2014","journal-title":"PLoS One"},{"key":"zoi190694r7","unstructured":"MannJFE, HilgersKF. Use of thiazide diuretics in patients with primary (essential) hypertension. 2017. https:\/\/www.uptodate.com\/contents\/use-of-thiazide-diuretics-in-patients-with-primary-essential-hypertension. Accessed October 31, 2019."},{"key":"zoi190694r38","unstructured":"Healthcare Cost and Utilization Project. Elixhauser comorbidity software version 3.7. https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/comorbidity\/comorbidity.jsp. Accessed November 18, 2019."},{"key":"zoi190694r39","unstructured":"Healthcare Cost and Utilization Project. Elixhauser Comorbidity Software for ICD-10-CM. https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/comorbidityicd10\/comorbidity_icd10.jsp. Accessed November 18, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2758006\/vouri_2019_oi_190694.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T08:40:47Z","timestamp":1613292047000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2758006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.18425","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]}}}